Rtw Investments, LP Profound Medical Corp. Transaction History

Rtw Investments, LP

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2021 Feb 14, 2022	SELL	$10.38 - $15.2 $1.27 Million - $1.86 Million	-122,098 Closed	0 $0
Q4 2020 Feb 16, 2021	SELL	$16.4 - $22.9 $2 Million - $2.8 Million	-122,095 Reduced 50.0%	122,098 $2.51 Million
Q3 2020 Nov 16, 2020	BUY	$14.05 - $18.13 $983,500 - $1.27 Million	70,000 Added 40.19%	244,193 $4.31 Million
Q1 2020 May 15, 2020	BUY	$6.88 - $19.7 $1.2 Million - $3.43 Million	174,193 New	174,193 $1.7 Million

8.93M

1.2K

Ticker PROF
Exchange NASDAQ
Sector Healthcare
Industry Medical Devices
Shares Outstandng 20,851,300
Market Cap $160M
Description
Profound Medical Corp., together with its subsidiaries, operates as a commercial-stage medical device company that develops magnetic resonance guided ablation procedures for treatment of prostate disease, uterine fibroids, and palliative pain treatment in Canada, Germany, the United States, and Finland. Its lead product TULSA-PRO system used for...

Get notified when there are updates to the investment portfolio of Rtw Investments, LP, based on Form 13F filings with the SEC.

Stay updated on Rtw Investments, LP with notifications on news.